Profile
Carin Dahlquist is currently employed at Linklaters LLP since 2004.
Prior to this, she worked as a Legal Counsel at Q-Med AB from 2005 to 2006 and as a Senior Legal Counsel at GE UK Group from 2006 to 2015.
She also served as the Head-Legal & Intellectual Property at Swedish Orphan Biovitrum AB.
Dahlquist holds a graduate degree from the University of Lund and a graduate degree from New York University School of Law.
Former positions of Carin Dahlquist
| Companies | Position | End |
|---|---|---|
GE UK Group
 GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | General Counsel | 31/12/2014 |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | General Counsel | 31/12/2005 |
| SWEDISH ORPHAN BIOVITRUM AB | General Counsel | - |
Training of Carin Dahlquist
| University of Lund | Graduate Degree |
| New York University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private companies | 2 |
|---|---|
GE UK Group
GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Health Technology |
- Stock Market
- Insiders
- Carin Dahlquist
